Refocus On China: Ark Bio Evolves As It Plans Shanghai Listing

Eyes R&D In Less Crowded Sectors

 
• By Brian Yang
  
Poring Studio/Shutterstock.com
Ark Biosciences refocuses on hometurf, aiming for Shanghai IPO • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from China

More from Focus On Asia